Skip to content

XOMA Corporation XOMA Change in receivables

Change in receivables at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$1.69B-11,147%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$13.1M-1,256%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$474K-96.6%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's change in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's change in receivables?
XOMA Corporation (XOMA) reported change in receivables of -$325K in Q1 2026.
How has XOMA Corporation's change in receivables changed year-over-year?
XOMA Corporation's change in receivables decreased by 108.8% year-over-year, from $3.71M to -$325K.
What is the long-term trend for XOMA Corporation's change in receivables?
Over 3 years (2021 to 2025), XOMA Corporation's change in receivables has grown at a 255.5% compound annual growth rate (CAGR), from -$54K to $2.43M.
What does change in receivables mean?
Change in total receivables including trade and non-trade receivables.